Trial intelligence / Profile preview

Influence of cow's milk on erlotinib absorption

NL-OMON20698Recruiting

Sponsor
Erasmus MC
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of erlotinib and esomeprazole in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Erasmus MC. Primary endpoints: Erlotinib AUC with milk versus water without PPI and Erlotinib AUC with milk versus water with PPI. Started Dec 2016; status: recruiting.

02

Drugs

erlotinibesomeprazole
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NL-OMON20698.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20698.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call